James S Hanson - General Counsel, G1 Therapeutics, Inc

As of January 5, 2021


James S Hanson Net Worth

  • Net worth is estimated to be at least $56.8K
  • Owns at least 4,000 units of G1 Therapeutics, Inc stock

James S Hanson Trading

  • Largest purchase of shares was 1,000 units , worth over $32.51K on December 11, 2018
  • In total has made about 6 transactions over 3 years
  • Usually trades in December and January, with the busiest year in 2018 and 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

James S Hanson Mailing Address

  • Mailing address is 79 TW Alexander Drive 4501 Research Commons, Suite 100 Research Triangle Park NC 27709 NC

G1 Therapeutics, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
John E. Bailey, Jr. 2020 - $542,109 - $215,948 $758,057
Mark A. Velleca, M.D., Ph.D. 2020 $608,308 $3,069,704 $305,000 $8,550 $3,991,562
Mark A. Velleca, M.D., Ph.D. 2019 $589,700 $3,105,237 $280,108 $8,400 $3,983,445
Mark A. Velleca, M.D., Ph.D. 2018 $515,000 $1,044,529 $321,875 $33,250 $1,914,654
Jennifer K. Moses 2020 $398,583 $1,116,239 $141,050 $8,550 $1,664,422
Jennifer K. Moses 2019 $315,598 $972,601 $117,600 $8,400 $1,414,199
Mark Avagliano 2020 $431,417 $837,165 $151,200 $18,445 $1,438,227
Mark Avagliano 2019 $181,913 $5,100,560 $142,800 $53,117 $5,478,390
Rajesh K. Malik, M.D. 2020 $424,000 $836,733 $148,750 $8,550 $1,418,033
Rajesh K. Malik, M.D. 2019 $413,000 $828,195 $138,768 $8,400 $1,388,363
Rajesh K. Malik, M.D. 2018 $400,000 $696,968 $169,400 $8,250 $1,274,618
Soma Gupta 2020 $320,360 $2,212,758 $114,662 $100,000 $2,747,780
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1560241/000119312521136977/d122680ddef14a.htm

G1 Therapeutics, Inc Insider Trading

  • The most recent transaction was 30,000 units sold on July 15, 2021 by Mark Velleca worth over $570.26K
  • In the last 4 years, insiders at G1 Therapeutics, Inc sold an estimated value of $67.24M and bought an estimated value of $25.67M
  • The most active traders are Rajesh Malik, Chief Medical Officer,  Mark Velleca,  and Jennifer Moses, CFO
  • Insider trading is most common in June, with the busiest year in 2018

G1 Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1